World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
23280
World Ranking
11467
National Ranking
126

Overview

Chunsheng Kang is affiliated with Tianjin Medical University General Hospital in China. Their research activity spans multiple fields, primarily focusing on Biochemistry, Genetics and Molecular Biology with 106 publications, and Medicine with 64 publications.

The scientist's subfields of study include Molecular Biology, Cancer Research, Genetics, Immunology, and Oncology. Their work covers topics such as Glioma Diagnosis and Treatment, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, RNA modifications and cancer, Immune cells in cancer, Extracellular vesicles in disease, and CRISPR and Genetic Engineering.

Chunsheng Kang has published several scientific papers, with recent examples including:

  • Clinical practice guidelines for the management of adult diffuse gliomas, 2020, Cancer Letters
  • FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury, 2020, Redox Biology
  • Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy, 2020, Theranostics
  • Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy, 2020, Biomaterials
  • Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy, 2022, Neuro-Oncology

The scientist has collaborated frequently with researchers including Qixue Wang, Xiaoteng Cui, Yunfei Wang, Yanli Tan, and Kaikai Yi.

Chunsheng Kang has published extensively in the following venues:

  • Theranostics (11 publications)
  • Neuro-Oncology (8 publications)
  • Frontiers in Immunology (5 publications)
  • Cancer Letters (4 publications)
  • Cancer Biology and Medicine (4 publications)

In addition to journal articles, Kang has contributed to book publications, including a title published by Frontiers Media: "The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?" (2021).

Best Publications

  • Non-coding RNAs as regulators in epigenetics (Review)

    Jian-Wei Wei;Kai Huang;Chao Yang;Chun-Sheng Kang

  • CGCG clinical practice guidelines for the management of adult diffuse gliomas

    Tao Jiang;Do-Hyun Nam;Zvi Ram;Wai-Sang Poon

  • Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.

    Xuan Zhou;Yu Ren;Lynette Marie Moore;Mei Mei

  • Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.

    Hongzhao Qi;Chaoyong Liu;Lixia Long;Yu Ren

  • MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

    Chun-Zhi Zhang;Jun-Xia Zhang;An-Ling Zhang;Zhen-Dong Shi

  • Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier.

    Jiang Chang;Youssef Jallouli;Maya Kroubi;Xu-bo Yuan

  • Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth.

    P Pu;Z Zhang;C Kang;R Jiang

  • Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2.

    Qun Chen;Qun Chen;Jinquan Cai;Jinquan Cai;Qixue Wang;Yunfei Wang

  • MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol

    Yu Ren;Xuan Zhou;Mei Mei;Xu-Bo Yuan

  • HOTAIR, a cell cycle–associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma

    Jun-Xia Zhang;Lei Han;Zhao-Shi Bao;Ying-Yi Wang

  • Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an EZH2 dependent manner.

    Kailiang Zhang;Xiaotian Sun;Xuan Zhou;Lei Han

  • MiRNA-451 plays a role as tumor suppressor in human glioma cells.

    Yang Nan;Lei Han;Lei Han;Anling Zhang;Guangxiu Wang

  • LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.

    Lei Han;Kailiang Zhang;Zhendong Shi;Junxia Zhang

  • miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression

    Wei Zhang;Jing Zhang;Katherine Hoadley;Deepa Kushwaha

  • Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro.

    Yu Ren;Chun-Sheng Kang;Xu-Bo Yuan;Xuan Zhou

  • A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.

    Qixue Wang;Junxia Zhang;Yanwei Liu;Wei Zhang

  • Paracrine and epigenetic control of CAF-induced metastasis: the role of HOTAIR stimulated by TGF-ß1 secretion.

    Yu Ren;Huan-huan Jia;Yi-qi Xu;Xuan Zhou

  • Star-branched amphiphilic PLA-b-PDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma.

    Xiaomin Qian;Lixia Long;Zhendong Shi;Chaoyong Liu

  • Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma

    Ningning Cong;Ping Du;Anling Zhang;Fajuan Shen

  • MicroRNA miR-451 downregulates the PI3K/AKT pathway through CAB39 in human glioma

    Yuan Tian;Yang Nan;Lei Han;Anling Zhang

Frequent Co-Authors

Yunfeng Lu
Yunfeng Lu University of California, Los Angeles
Wei Zhang
Wei Zhang Central South University
Linqi Shi
Linqi Shi Nankai University
Irvin S. Y. Chen
Irvin S. Y. Chen University of California, Los Angeles
Yingli An
Yingli An Nankai University
Bing-Hua Jiang
Bing-Hua Jiang Zhengzhou University
wei zhang
wei zhang Wake Forest University
Wei Chen
Wei Chen Northwestern University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The landscape of medical education is rapidly evolving, with more students opting for flexible online programs to progress their healthcare careers. Online degrees offer accessible routes into vital fields beyond the traditional MD pathway, providing new professional opportunities.

If you’re interested in nutrition and wellness, an online dietitian degree enables you to study evidence-based nutrition and qualify for roles in health promotion, community programs, or clinical support. Those aspiring to leadership and management positions in healthcare settings can explore a wide range of cahme accredited online mha programs list for advanced skills in healthcare administration.

For registered nurses seeking to boost qualifications without additional clinical requirements, online rn to bsn programs no clinicals offer a practical and efficient solution. Meanwhile, nurses aiming for leadership or specialized practice may consider the shortest dnp program online to accelerate their pathway to a Doctor of Nursing Practice degree.

These related online degrees give students diverse entry points and career paths within the broader healthcare sector, making it easier to specialize or advance without relocating or interrupting work.

Best Scientists Citing Chunsheng Kang

Trending Scientists

Recently Published Articles